Leadership

Executive Committee

The Executive Committee is the peak management group of the Kirby Institute. The Executive Committee is responsible for scientific planning, and provides high-level oversight on matters of strategic direction and operational significance to the Institute. The Committee also reviews the advice and recommendations of the Strategic Advisory Group. Members of the Executive Committee are:

 

Professor Anthony Kelleher  

Scientia Professor Anthony Kelleher
Director

   
Dr Deborah Cromer  

Dr Deborah Cromer
Early/Mid-Career Researcher Representative

 

   
Professor Miles Davenport  

Professor Miles Davenport
Program Head, Infections Analytics Program

   
Scientia Professor Gregory Dore  

Scientia Professor Gregory Dore
Program Head, Viral Hepatitis Clinical Research Program

   
Mr Daren Draganic  

Mr Daren Draganic
Manager, Kirby Institute

 

   
Professor Andrew Grulich  

Scientia Professor Andrew Grulich
Program Head, HIV Epidemiology and Prevention Program

 

   
Professor Rebecca Guy  

Professor Rebecca Guy
Program Head, Surveillance and Evaluation Research Program

   
Scientia Professor John Kaldor  

Scientia Professor John Kaldor
Program Head, Global Health Program

   
Professor Gail Matthews  

Professor Gail Matthews
Program Head, Therapeutic Vaccine and Research Program

   
Mr Robert Monaghan  

Mr Robert Monaghan
Manager, Aboriginal and Torres Strait Islander Health Research

   
Professor Virginia Wiseman  

Professor Virginia Wiseman
Chair, Strategic Advisory Group

 

Strategic Advisory Group

The Strategic Advisory Group will advise the Director and the Executive Committee on matters of strategic and operational significance to support and promote the success, impact and growth of the Kirby Institute. The Strategic Advisory Committee also supports the implementation of the Kirby Strategic Plan and reviews proposals brought forward by the Advisory Committees.

 

Director  

Scientia Professor Anthony Kelleher

 

Operations  

Ms Lucienne Bamford
Mr Daren Draganic

 

Program Heads  

Professor Miles Davenport
Professor Basil Donovan
Scientia Professor Gregory Dore
Professor Rebecca Guy
Scientia Professor Andrew Grulich
Scientia Professor John Kaldor
Professor Matthew Law
Professor Andrew Lloyd
Professor Raina MacIntyre
Professor Lisa Maher
Professor Gail Matthews

 

Group Leaders  

Dr Tanya Applegate
Dr Benjamin Bavinton
Associate Professor Rowena Bull
Dr Allison Carter
Dr Louise Causer
Dr Deborah Cromer
Professor Jason Grebely
Dr Mohamed Hammoud
Associate Professor Behzad Hajarizadeh
Associate Professor Angela Kelly-Hanku
Dr David Khoury
Associate Professor Fabio Luciani

Dr Skye McGregor
Professor Kathy Petoumenos
Associate Professor David Regan
Dr Sarah Sasson
Associate Professor Stuart Turville
Professor Andrew Vallely
Dr Lisa Vallely
Associate Professor Susana Vaz Nery
Professor Virginia Wiseman

 

Advisory Committee Chairs  

Ms Cate Carey
Ms Liza Doyle
Dr Skye McGregor
Scientia Professor John Kaldor
Professor Gail Matthews
Mr Robert Monaghan
Professor Virginia Wiseman

 

Senior Professional Staff Representatives   

Dr Michelle Bonello
Ms Marianne Byrne

Mr Phillip Keen
Dr Rebekah Puls

 

Postgraduate Coordinator  

Associate Professor David Regan
Dr Chantelle Ahlenstiel

 

Postgraduate Student Representative  

Ms Yumi Sheehan

 

Equity Diversity and Inclusion Committee Chair  

Dr Bridget Haire

 

 

Kirby Institute Strategic Plan 2019–2023

The Kirby Institute Strategic Plan was launched in 2019 with the goal of ensuring that our Institute is the best possible position to respond to the many urgent questions and pressing issues that remain unsolved as we pursue our ultimate goal: a world free from infectious disease.

As we look to the near future, we will be taking what we’ve learnt and applying those insights and approaches to other infectious diseases and to a greater diversity of at-risk communities and populations. We will be building our capacity to discover, develop and implement interventions in our existing and emerging fields of infectious disease research.

Events